Bio-Techne Corp. (TECH) is a publicly traded Healthcare sector company. As of October 28, 2026, TECH trades at $72.71 with a market cap of $11.39B and a P/E ratio of 61.94. TECH moved +0.11% today. Year to date, TECH is +21.86%; over the trailing twelve months it is +13.68%. Its 52-week range spans $43.20 to $72.75. Analyst consensus is neutral with an average price target of $73.00. Rallies surfaces TECH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks TECH insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $72.71 |
| Market Cap | $11.39B |
| P/E Ratio | 61.94 |
| EPS | $1.17 |
| Dividend Yield | 0.08% |
| 52-Week High | $72.75 |
| 52-Week Low | $43.20 |
| Volume | 2.37M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.22B |
| Net Income | $181.86M |
| Gross Margin | 65.77% |
2 analysts cover TECH: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $73.00.